Buy ORTHOVISC® online in Canada at Kinami Health and order genuine sodium hyaluronate injections for professional orthopaedic use. ORTHOVISC® is a high-molecular-weight, non-animal hyaluronic acid (HA) viscosupplement designed for intra-articular injection in patients with knee osteoarthritis. It supports joint lubrication, cushioning and mobility when the natural synovial fluid becomes reduced or less effective. Kinami Health supplies authentic ORTHOVISC® products to Canadian clinics and medical professionals, with wholesale options and reliable delivery.
Buy ORTHOVISC® online in Canada at Kinami Health and order genuine sodium hyaluronate injections for professional orthopaedic use. ORTHOVISC® is a high-molecular-weight, non-animal hyaluronic acid (HA) viscosupplement designed for intra-articular injection in patients with knee osteoarthritis. It supports joint lubrication, cushioning and mobility when the natural synovial fluid becomes reduced or less effective. Kinami Health supplies authentic ORTHOVISC® products to Canadian clinics and medical professionals, with wholesale options and reliable delivery.
Kinami Health provides Canadian clinics, orthopaedic specialists and medical distributors with trusted access to genuine ORTHOVISC® products, with professional support, competitive wholesale pricing and fast delivery for clinical use. ORTHOVISC® is selected by practitioners looking for a non-animal HA viscosupplement with a high-molecular-weight formulation, used as a knee osteoarthritis injection to help restore joint lubrication and support smoother movement.
Benefits of ordering ORTHOVISC® from Kinami Health include:
ORTHOVISC® 2 mL prefilled syringe – a sodium hyaluronate viscosupplement for intra-articular injection in the knee joint. It supplements the natural synovial fluid in patients with knee osteoarthritis, helping improve lubrication and cushioning inside the joint.
ORTHOVISC®, Synvisc and Monovisc are all viscosupplement injections used in the management of knee osteoarthritis, but they differ in formulation, injection schedule and HA source.
ORTHOVISC® is a high-molecular-weight, non-animal sodium hyaluronate viscosupplement produced through bacterial fermentation, commonly used as a multi-injection course. Synvisc contains hylan G-F 20 and, being very well known across North America, is the comparison Canadian clinics most often make against ORTHOVISC®. Monovisc is a single-injection HA viscosupplement, which may be preferred when a one-injection protocol is suitable, while ORTHOVISC® may be selected for a multi-injection plan.
When comparing these options, Canadian clinics usually consider the injection protocol (single vs multi-injection course), the HA source (non-animal HA vs hylan-based), molecular weight and viscosity, patient needs and practitioner preference.
ORTHOVISC® works by supplementing the natural synovial fluid in the knee joint. In osteoarthritis, synovial fluid can lose viscosity and elasticity, reducing its ability to lubricate and cushion the joint. ORTHOVISC® contains sodium hyaluronate, a form of hyaluronic acid that helps restore joint lubrication and support smoother movement.
As a high-molecular-weight HA viscosupplement, ORTHOVISC® is designed to improve the mechanical environment inside the knee joint and may help reduce OA-related pain and support mobility. It is typically administered as a series of intra-articular injections; the number of injections and schedule should be determined by a qualified professional based on the patient’s condition and treatment goals.
ORTHOVISC® should only be administered by trained, qualified medical professionals experienced in intra-articular injection techniques. In Canada, who may administer intra-articular injections varies by province and professional college, so practitioners should follow the rules that apply in their own jurisdiction.
Before injection, the treatment area should be prepared using appropriate aseptic technique. If joint effusion is present, aspiration may be performed first. The product is injected directly into the affected knee joint using a suitable sterile needle, commonly in the 18-21G range depending on practitioner preference and protocol. General considerations include:
ORTHOVISC® is generally well tolerated when administered correctly. As with other intra-articular HA injections, side effects may occur at or around the injection site, including temporary pain or discomfort, swelling, warmth or redness, stiffness, bruising or mild local irritation.
Patients should be assessed before treatment to confirm suitability. ORTHOVISC® should not be used in patients with known hypersensitivity to any component, or where infection or skin disease is present at the injection site. In Canada, adverse reactions can be reported to Health Canada.
Switching region will update prices and available products.
